CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.041
https://www.valueinhealthjournal.com/article/S1098-3015(17)30375-3/fulltext
Title :
CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30375-3&doi=10.1016/j.jval.2017.08.041
First page :
A405
Section Title :
BREAKOUT SESSION VIII
Open access? :
No
Section Order :
35